Medication

Latest

10 Top Myths About Bipolar Disorder

There's a lot that's not understood about bipolar. Get the facts from someone who knows what it's really like to live with this form of mental illness.

By Julie A. Fast

Secondary Progressive Multiple Sclerosis Finally Has Two New FDA-Approved Treatments

The new medications, siponimod (Mayzent, Novartis) and cladribine (Mavenclad, EMD Serono), bring treatment options to active secondary progressive multiple sclerosis (SPMS). Most treatments approved for MS are for relapsing, rather than progressive, forms of the disease.

By Lisa Emrich

The Insider’s Guide to Using Suppositories

Take it from someone who knows — although it can seem unpleasant, these tips can help you learn how to handle using suppositories for ulcerative colitis or Crohn’s.

By Mandy Morgan

Options Exist

Multiple sclerosis treatment is one of the fastest moving areas of medicine.

Slowing Down Long-Term Progression of Multiple Sclerosis With Disease-Modifying Therapies

A number of disease-modifying therapies (DMTs) are effective in decreasing the frequency of relapses and the number of lesions in the brain or spinal cord.

By Lisa Emrich

FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis

Patients living with multiple sclerosis (MS) in the US may try these disease-modifying therapies (DMTs) to slow down the long-term progression of the disease.

By Lisa Emrich

Drugs to Take (And Not to Take) When Pregnant With MS

Multiple sclerosis requires you to learn large amounts of information. During pregnancy, one concern is your MS medication.

By Lisa Emrich

Demand for IUDs Is Up — Here's Why

President Trump recently ramped up his promise to get rid of the Affordable Care Act, sometimes called Obamacare. Here’s how women are reacting, according to a new study.

By Lara DeSanto

Weight Loss Drug Reduces Diabetes Risk

If you have prediabetes or type 2 diabetes, pay attention to this study that discovered this weight loss drug can lower your blood sugar and diabetes risk.

By Mary Shomon

Over Half of Eligible Patients Aren't Offered a Statin

Nearly 59 percent of American adults who meet guidelines for statin therapy to lower cholesterol say their physicians hadn’t given them a statin option.

By Diane Domina